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Abstract: Human milk is the ideal nutrition source for healthy infants during the first six months of
life and a detailed characterisation of the composition of milk from mothers that deliver prematurely
(<37 weeks gestation), and of how human milk changes during lactation, would benefit our
understanding of the nutritional requirements of premature infants. Individual milk samples from
mothers delivering prematurely and at term were collected. The human milk metabolome, established
by nuclear magnetic resonance (NMR) spectroscopy, was influenced by gestational and lactation age.
Metabolite profiling identified that levels of valine, leucine, betaine, and creatinine were increased in
colostrum from term mothers compared with mature milk, while those of glutamate, caprylate, and
caprate were increased in mature term milk compared with colostrum. Levels of oligosaccharides,
citrate, and creatinine were increased in pre-term colostrum, while those of caprylate, caprate, valine,
leucine, glutamate, and pantothenate increased with time postpartum. There were differences
between pre-term and full-term milk in the levels of carnitine, caprylate, caprate, pantothenate, urea,
lactose, oligosaccharides, citrate, phosphocholine, choline, and formate. These findings suggest that
the metabolome of pre-term milk changes within 5–7 weeks postpartum to resemble that of term
milk, independent of time of gestation at pre-mature delivery.
Keywords: pre-term; infant; nutrition; human milk; metabolites; NMR; metabolomics
1. Introduction
Human milk (HM) is the recognised gold standard for feeding new-born full-term healthy infants.
HM is a unique food source that contains all the exacting amounts of required nutrients to support the
growth and development of term infants during the first six months of life. The health benefits of HM
have been well documented [1]. Current data suggest that the quantity of HM consumed by healthy
term infants is on average 0.778 kg human milk/day, with males consuming 0.056 kg/day more than
females. Human milk consumption rises rapidly during the first month postpartum to ~0.6 kg/day
and increases to ~0.82 kg/day in 3–4 month old infants [2].
Human milk is also regarded as particularly important for feeding pre-mature infants. There are
many health benefits related to providing a pre-term infant with HM, including improvements in
digestion, nutrient absorption, gastrointestinal function, and neurodevelopment of the infant [3,4].
In addition, an exclusive HM diet has been associated with lower rates of necrotizing enterocolitis,
a potentially fatal gastrointestinal complication, in premature infants [5]. Human milk oligosaccharides
(HMO) are known to affect the gut microbiota and it has been speculated that HMOs could account for
the lower observed incidences of necrotizing enterocolitis [6].
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Mother’s milk is inadequate for rapidly growing pre-term neonates, which can be ascribed to
a higher protein and energy requirement of pre-term neonates, particularly those of low birth weight
and <28 weeks gestation, leading to insufficient weight gain and nutrition deficits [7,8]. For extremely
pre-term and very low birth weight infants, the fortification of HM using commercial fortifiers is often
recommended in order to supply the neonate with the nutrients required to support its rapid rate of
growth. Studies have shown that the addition of HM fortifier can improve weight, length, and head
circumference growth, in addition to bone mineralization and neurological outcomes [9–13].
It is known that the composition of pre-term milk differs from that of milk of full-term mothers,
with higher reported levels of total protein, fat, carbohydrate and energy in pre-term milk [14].
Differences in the proteome of the two types of milk have also been reported [15]. Generally, studies
have focused on the macronutrient content of pre-term and term HM without consideration of
micronutrients such as biologically significant metabolites [14].
Previous work on milk metabolomes has predominantly considered bovine milk [16–20] and
human milk [21–28]. Recently, a multi-analytical platform study identified 710 metabolites in
human milk by using a combination of MS- and NMR-based analytical techniques [21]. Moreover,
a recent study identified subtle differences between some milk metabolites during the first month of
lactation [27]. However, the changes in pre-term and full-term human milk metabolomes over a full
lactation time course have not yet been reported in detail.
In this study, we report how gestational age affects the low-molecular-weight metabolome of HM
from mothers of pre-term and term infants over range of stages of lactation. The milk metabolomes
were compared using proton nuclear magnetic resonance spectroscopy (1H NMR)-based metabolomics
from milk samples from mothers at different gestational ages. Longitudinal samples were also
examined to analyse how pre-term milk develops with time postpartum compared with term milk.
2. Materials and Methods
2.1. Ethical Approval
Ethical approval for this study was granted by The Clinical Research Ethics Committee of the
Cork Teaching Hospitals, Cork, Ireland (clinical number reference ECM 4(s) 06/08/13).
2.2. Samples and Sample Collection
2.2.1. Pre-term Samples
Multiple frozen (´20 ˝C) longitudinal pre-term HM samples were collected from 15 individual
mothers of pre-term infants (Table 1). The HM samples were collected from the freezers of the neonatal
intensive care unit of Cork University Maternity Hospital (Wilton, Co. Cork, Ireland). Each bottle
of HM was dated allowing for an accurate calculation of the gestational age of the infant when the
milk was expressed. The HM samples from each individual mother were pooled according to ‘day
postpartum’ up to 14 days and according to ‘week postpartum’ after this, creating n = 62 pre-term
HM samples. For one donor (Pre-1), information on number of days postpartum was unavailable and
accordingly samples from this donor were removed from multivariate models using gestational age or
days postpartum for modelling or visualization purposes.
2.2.2. Full-term Samples
Frozen (´20 ˝C) HM samples (n = 30) were obtained from The Western Trust Milk Bank,
Irvinestown, Co. Fermanagh, Ireland (Table 2). The HM samples were from 30 individual mothers of
healthy full-term infants who donated milk with consent for use for research purposes. The mothers
expressed milk in a domestic setting and stored milk at ´20 ˝C before shipping to The Western Trust
Milk Bank, Ireland. HM was pasteurised and microbiologically screened before being frozen and
shipped to University College Cork where it was stored at ´20 ˝C. Milk samples were categorized
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according to the length of time postpartum; colostrum (<5 days postpartum; n = 5), transitional
(6 days–2 weeks postpartum; n = 4), mature (>2 weeks, n = 21).
Table 1. Sample information from mothers of pre-term infants.
Sample
Id
Secretor
Status Gestation
Infant
Weight,
Grams
Age of
Mother,
Years
Gravida 1 Para 2
Number of
Samples
Postpartum
Span 3
Pre 01 Se+ – – – – – 4 –
Pre 02 Se+ 38 weeks 3210 35 2 2 4 7–11 weeks
Pre 03 Se+ 28 weeks 1190 33 1 1 9 4–12 days
Pre 04 Se+ 31 weeks 1830 36 3 3 5 1–5 weeks
Pre 05 Se+ 30 weeks 1340 29 1 1 7 4 days–7 weeks
Pre 06 Se+ 32 weeks+ 2 days 2340 42 2 2 1 8 days
Pre 07 Se´ 24 weeks+ 4 days 540 33 1 1 4 1–4 days
Pre 08 Se´ 31 weeks 1680 35 2 2 2 5–14 weeks
Pre 09 Se+ 35 weeks+ 6 days 2410 33 1 1 3 2–5 weeks
Pre 10 Se+ 35 weeks+ 2 days 3100 26 1 1 2 4–5 days
Pre 11 Se+ 33 weeks+ 4 days 1800 29 6 5 2 4–6 days
Pre 12 Se+ 35 weeks+ 4 days 3260 45 4 3 + 2
4 2 9–10 days
Pre 13 Se+ 26 weeks 650 40 – – 15 6 days–8 weeks
Pre 14 Se´ 28 weeks+ 3 days – – – – 1 13 weeks
Pre 15 Se+ 32 weeks – – – – 1 9 weeks
1 Number of pregnancies, including the current pregnancy; 2 number of times the mother has given birth; 3
time range indicates days postpartum of first and last samples from that donor; 4 indicates twin pregnancy.
2.3. NMR Spectroscopy
NMR spectroscopy was essentially performed as described earlier [29]. Briefly, the samples
skimmed by centrifugation at 4000 g for 15 min and removal of the top fat layer before filtering
to remove residual lipids and protein using Amicon Ultra 0.5 mL 10 kDa (Millipore, Billerica, MA,
USA) spin filters at 10,000 g for 30 min at 4 ˝C. A filtered sample (500 µL) was mixed with 100 µL
D2O containing 0.025% 3-(trimethylsilyl) propionic-2,2,3,3-d4 acid, sodium salt (TSP; Sigma-Aldrich,
St. Louis, MO, USA) as an internal chemical shift reference. 1H NMR spectroscopy was performed
at 298 K on a Bruker Avance III 600 spectrometer, operating at a 1H frequency of 600.13 MHz, and
equipped with a 5-mm 1H TXI probe (Bruker BioSpin, Rheinstetten, Germany). The sample sequence
was randomized prior to acquisition and standard one-dimensional spectra were acquired using
a single 90˝ pulse experiment with a relaxation delay of 5 s. Water suppression was achieved by
irradiating the water peak during the relaxation delay, and a total of 64 scans were collected into
32,768 data points spanning a spectral width of 12.15 ppm. All 1H spectra were initially referenced
to the TSP signal at 0 ppm. Prior to Fourier transformation, the data were multiplied by a 0.3 Hz
line-broadening function. The proton NMR spectra were phase and baseline corrected manually using
Topspin 3.2 (Bruker Biospin, Rheinstetten, Germany). NMR signals were assigned in accordance
with existing literature [20,21,25,29], 2D NMR spectroscopy, Chenomx NMR Suite 8.1.2 (Chenomx Inc,
Edmonton, AB, Canada) and the Human Metabolome Database [30].
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Table 2. Sample information from mothers of term infants.
Sample ID Secretor status Time postpartum Group
Term 01 Se+ <5 days Colostrum
Term 02 Se+ <5 days Colostrum
Term 03 Se+ <5 days Colostrum
Term 04 Se+ <5 days Colostrum
Term 05 Se+ <5 days Colostrum
Term 06 Se+ 2 weeks Transitional
Term 07 Se+ 2 weeks Transitional
Term 08 Se´ 6 days Transitional
Term 09 Se´ 2 weeks Transitional
Term 10 Se´ 15 weeks Mature
Term 11 Se´ 9 weeks Mature
Term 12 Se+ 15 weeks Mature
Term 13 Se´ 11 weeks Mature
Term 14 Se´ 15 weeks Mature
Term 15 Se´ 11 weeks Mature
Term 16 Se+ 16 weeks Mature
Term 17 Se´ 9 weeks Mature
Term 18 Se+ 19 weeks Mature
Term 19 Se+ 24 weeks Mature
Term 20 Se+ 11 weeks Mature
Term 21 Se+ 7–10 weeks Mature
Term 22 Se+ 13 weeks Mature
Term 23 Se+ 13 weeks Mature
Term 24 Se+ 14 weeks Mature
Term 25 Se+ 5 weeks Mature
Term 26 Se+ 27 weeks Mature
Term 27 Se´ 33 weeks Mature
Term 28 Se´ 27 weeks Mature
Term 29 Se+ 29 weeks Mature
Term 30 Se+ 33 weeks Mature
2.4. Secretor Status
Maternal secretor status was determined as previously described [25]. In brief the absence
or presence of 2-FL was used to determine secretor status quantified by NMR spectroscopy (2-FL
corresponds to NMR signal at δ 5.32 ppm). Milk from mothers classified as non-secretors did not have
any detectable levels of 2-FL, whereas milk from mothers classified as secretors did contain 2-FL.
2.5. Multivariate Data and Statistical Analyses
NMR spectra of milk samples were aligned using Icoshift by co-shifting of the whole spectra
according to the anomeric lactose proton at 5.23 ppm [31]. The proton NMR spectra were subdivided
into 0.01 ppm bins, reducing each spectrum into 957 separate variables in the regions 10.00–5.00 and
4.72–0.5 ppm. Principal component analysis (PCA) and orthogonal partial least squares discriminant
analysis (OPLS-DA) were performed in order to identify differences in the metabolite profiles. The data
was mean-centred and Pareto-scaled prior to analysis. The OPLS-DA model was cross-validated
using segmentation with seven splits. Covariance was investigated by analysis of OPLS-DA
regression coefficients back-transformed to original data and colour coded by the loading weights [32].
The multivariate data analysis was performed using SIMCA-P + 13 (Umetrics AB, Umeå, Sweden).
Alignment by Icoshift, binning, and analysis of OPLS-DA plots were performed in MATLAB 7.13 using
in-house developed scripts (MathWorks Inc., Natick, MA, USA). Univariate statistical significance was
evaluated by Student’s t-test using the Statistics Toolbox in MATLAB 7.13 (MathWorks Inc., Natick,
MA, USA).
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3. Results
HM samples (n = 92) were collected from 45 individual mothers with different gestational ages at
delivery, ranging from 24.6–35.8 weeks in the case of pre-term samples and more than 37 weeks for
full-term samples (Tables 1 and 2). For pre-mature deliveries, infant birth weight ranged from 540 g
to 3260 g. Age of the mothers of pre-term infants ranged from 26–45 years, and all had at least one
previous pregnancy longer than 24 weeks gestation (Table 1).
The median spectrum of all 92 milk samples is shown in Figure 1. Each signal corresponds
to proton resonances in milk metabolites according to assignments in Table 3. Differences in
fucosylated human milk oligosaccharides (HMO) have previously been described to depend on
maternal secretor status [33]. Accordingly, secretor status of the mothers was determined by examining
the specific patterns of fucosylated oligosaccharides (Figure 1B) [25]. Thirteen mothers were found to
be non-secretors, accounting for 28.9% of the mothers included in the study (Tables 1 and 2).
The collected milk samples were analysed for changes during lactation following both full-term
(Figure 2) and pre-term (Figure 3) delivery. Figure 2 shows a scores plot of principal component (PC) 2
and PC3 from a principal component analysis (PCA) model of full-term milk samples. The samples are
grouped into colostrum, transitional, and mature groups and coloured according to days postpartum.
The scores plot shows the distinct groupings of the milk samples, and indicates a gradual change in the
milk metabolome as the milk develops from colostrum towards mature milk (Figure 2). In addition,
no detectable differences were observed between mature milk samples in the intervals before 26 weeks
and after 26 weeks (Figure 2). There was an apparent difference in milk metabolites depending on
secretor status in term milk samples, as the milk samples were separated into secretor or non-secretor
groups along PC2 (Figure 2).Nutrients 2016, 8, 304  6 of 17 
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Figure 1. Median 1H NMR spectrum of 92 human milk samples. (A) Aliphatic region 4.6–0 ppm
(B) Human milk oligosaccharides in 5.45–5.00 ppm region; and (C) aromatic region 9.7–5.5 ppm region.
For peak assignments refer to Table 3.
Nutrients 2016, 8, 304 6 of 15
Table 3. List of metabolites in human milk with chemical shifts in ppm from internal TSP standard and
assignment of resonances.
# Metabolite
1H Chemical
shift (ppm)
Assignment # Metabolite
1H Chemical
shift (ppm)
Assignment
1 Caprylate
0.85 CH3 29 Methanol 3.37 CH3
1.53 CH2 30 Lactose 3.23, 3.5–4.0 Multiple
2 Caprate
0.85 CH3 31 Gluconate 4.05 CH
1.53 CH2 32 Galactose 4.57 CH
3 Butyrate
0.88 CH3 33
Fuc α1,4
GlcNAc 5.03 CH-1
1.55 β-CH2 34
Fuc α1,3
GlcNAc 5.19 CH-1
2.16 α-CH2
35 LNDFH II
5.03 Fuc (α1-4) CH-1
4 Pantothenate 0.91 CH3 5.38 Fuc (α1-3) αGlc CH-1
5 Leucine 0.94 CH3 5.43 Fuc (α1-3) βGlc CH-1
6 Valine
0.98 γ-CH3 36 LNDFH I
5.16 Fuc (α1-2) CH-1
1.03 γ’-CH3 5.03 Fuc (α1-4) CH-1
7 3-BHBA
1.18 CH3 37 LNFP III
5.11 Fuc (α1-3) GlcNAc CH-1
2.39 CH2 5.13 Fuc (α1-3) GlcNAc CH-1
8 Fucosyl moieties
1.19 CH3-6
38 LDFT
5.29 Fuc (α1-2) CH-1
1.23–1.29 CH3-6 5.4 Fuc (α1-3) αGlc CH-1
9 Lactate 1.32 CH3 5.46 Fuc (α1-3) βGlc CH-1
10 Alanine 1.47 CH3 39 LNFP I 5.32 Fuc (α1-2) CH-1
11 6’-SL 1.73 CH3 40 2’FL 5.32 Fuc (α1-2) CH-1
12 3’-SL 1.78 CH3 41 3’FL
5.39 Fuc (α1-3) αGlc CH-1
13 Acetate 1.91 CH3 5.44 Fuc (α1-3) βGlc CH-1
14 GlcNAc 2.04 CH3 42 LNFP V
5.39 Fuc(α1-3)αGlc CH-1
15 Sialic acid 2.06 CH3 5.44 Fuc (α1-3) βGlc CH-1
16 Glutamate
2.12 β-CH2 43 Urea 5.76 NH2
2.33 γ-CH2 44 Fumarate 6.51 CH = CH
17 Methionine 2.13 CH3 45 Tyrosine
6.9 CH-3,5
18 Glutamine
2.11 β-CH2 7.2 CH-2,6
2.46 γ-CH2 46 Methylhistidine
7.06 CH-4
19 Citrate
2.51 α-CH2 7.8 CH-2
2.69 α’-CH2
47 Phenylalanine
7.32 CH-2,6
20 Dimethylamine 2.72 2 CH3 7.37 CH-4
21 2-oxogluturate 2.99 CH2 7.42 CH-3,5
22 Creatinine 3.02 CH3
48 Hippurate
7.54 CH-2,6
23 Creatine 3.03 CH3 7.63 CH-4
24 Malonate 3.12 CH2 7.82 CH-3,5
25 Choline 3.19 3 CH3 49 Formate 8.44 CH
26 O-Phosphocholine
3.21 3 CH3
50
Cytidine
triphosphate
5.99 CH-2
4.16 CH2 6.13 CH-10
27 Carnitine
2.42 CH2 7.97 CH-11
3.21 3 CH3
51 Uridine
5.89 CH-2
28 Betaine 3.24 3 CH3 5.91 CH-10
7.87 CH-11
Abbreviations: 3-BHBA, 3-betahydroxybutyrate; FL, fucosyllactose; Fuc, Fucose; GlcNAc, N-acetylglucosamine;
LDFT, lactodifucotetraose; LNDFH, lacto-N-difucohexaose, LNFP, lacto-N-fucopentaose; SL, sialyllactose.
Several milk metabolites were found to be present in significantly different concentration in
colostrum, transitional, and mature milk. Fucosylated oligosaccharides, and also components of
oligosaccharides (Fucose, N-acetylneuraminic acid, N-acetylglucosamine), were found at the highest
levels in colostrum, and levels decreased in mature milk samples (Figure 2B). Moreover, levels of
valine, leucine, pantothenate, citric acid, lactic acid, betaine, and creatinine were higher in colostrum
and transitional milk compared with mature HM, and levels of glutamate, butyrate, caprylate, and
caprate were higher in mature HM compared with colostrum and transitional milk. The level of
β-hydroxybutyrate was found to be independent of milk maturity in full-term HM (Figure 2B).
Milk from non-secretor mothers did not contain oligosaccharides with α1-2 fucosylated structures
(Figure 2B); however, the level of 3’ fucosyllactose (3’-FL) was increased in non-secretor mothers
compared with secretor mothers.
Similarly, the pre-term milk samples were also examined for an effect of stage of lactation
on the milk metabolome. The scores plot of a two component PCA model of milk samples from
pre-term mothers is shown in Figure 3, in which samples are coloured according to number of days
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postpartum. The scores and loadings plots clearly show the changes in milk metabolome occurring
over time in pre-term milk. Levels of fucosyl moieties, N-acetylneuraminic acid, N-acetylglucosamine,
3’-sialyllactose, 6’-sialyllactose, 2’-fucosyllactose, citric acid, choline, and creatinine decreased with
time postpartum (Figure 3B), while levels of 3-FL, lacto-N-difucohexaose I (LNDFH I), butyrate,
caprylate, caprate, lactic acid, valine, leucine, alanine, glutamate, and pantothenate increased with
time postpartum (Figure 3B). Only two mothers, who donated seven milk samples in total, were
identified as non-secretors (Table 1). Thus, it was not possible to identify differences in the PCA model
for pre-term samples on the basis of secretor status.Nutrients 2016, 8, 304  8 of 17 
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As some of the same time-related changes were apparent in both pre-term and full-term milk
samples, the difference between the pre-term and full-term milk metabolomes of similar days
postpartum was investigated. Citrate (P = 0.00057), lactose (P = 0.0039), and phosphocholine (P = 0.049
were found to be present in significantly higher levels in pre-term milk samples compared with
full-term milk samples (Figure 4). Citrate level is known to decrease with time postpartum [28], while
lactose is the major milk metabolite identified by NMR spectroscopy [20].
Thus, in the following analysis, NMR resonances originating from lactose were removed in order
to increase the weight of other metabolites in the multivariate models. A PCA of pre-term and full-term
milk samples (n = 88) was generated using two principal components which, together, explained 80.8%
of the total variance described by the PCA model (Figure 5). From the PCA model, it is apparent that
the milk metabolite profile from mothers of pre-term infants older than 5–7 weeks resembles that of
full-term milk, as they are positioned in close proximity to the full-term milk samples, independent of
time of gestation at delivery (Figure 5).
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OPLS-DA was also performed on the pre-term and full-term milk samples (Figure 6).
Full-term and pre-term colostrum and transitional milk were excluded from the analysis, due
to there being too few samples of these, and to be able to compare milk samples with similar
days postpartum. The OPLS-DA model shows that significant differences exist between the
metabolite profiles of pre-term and full-term milk (Figure 6B). In full-term milk, carnitine, caprylate,
caprate, pantothenate, beta-hydroxybutyrate, and urea were found to be present in higher levels
compared with pre-term milk, while lactose (Figure 4), Fucosyl moieties, N-acetylneuraminic acid,
N-acetylglucosamine, 3’-sialyllactose, 6’-sialyllactose, lacto-N-difucohexaose I (LNDFH I), glutamate,
citric acid, phosphocholine, choline, and formic acid were found in higher levels in pre-term milk
(Figure 6).Nutrients 2016, 8, 304  12 of 17 
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Figure 6. (A) Orthogonal partial least squares discriminant analysis of pre-term (n = 20, days
postpartum range 3–14 weeks) and full-term (n = 21, days postpartum range 3–26 weeks) milk.
Full-term colostrum, transitional, and pre-term milk <2 weeks postpartum have been excluded.
Cross-validation, Q2: 0.70; (B) corresponding OPLS-DA coefficients plot. Each variable has been
coloured according to the OPLS-DA loadings (correlation between NMR variables and pre-term/
full-term classes); for peak assignments refer to Table 3.
4. Discussion
Pre-mature birth is considered to have long-lasting adverse effects on health, and it has been
proposed that the intr duction of metab lomics technologi s may facilitate better understanding
f th se effects [34]. The exact causes of preterm delivery are not clear, but often ssociated with
inflammation [35]. In the present study, causes of the preterm delivery were ot known. In this study,
differences in metabolomic profiles of HM were associated with gestational age. Previous studies
have shown many health benefits of breast-feeding pre-term infants. However, mother’s milk may not
always be adequate for pre-term infants with high nutrition density requirements, which can lead to
insufficient weight gain and nutrition deficits. To date, only a few metabolomics studies have been
performed on pre-term human milk in the first few weeks of lactation [27]. To our knowledge, this is
the first study to comprehensively characterize and compare the pre-term and full-term human milk
metabolome over a lactation time-course (up to 14 weeks postpartum). Milk metabolomics may be
used in a clinical setting [23], in order to establish the milk metabolome for infant nutrition in cases
where the optimal nutrition is a key advantage as in pre-term infants. Milk metabolomics studies
in cows’ milk have previously shown an ability to yield information about the health status of the
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cow [29,36]. It can likewise be hypothesized that the milk metabolome of lactating mothers can give
information that can be used in a clinical setting.
Previous studies have shown that several factors influence the variability in the milk metabolome.
The epithelial cells in the mammary gland are accountable for the milk production, and these cells
are ultimately responsible for converting most precursors into milk components, but many other cell
types are also involved in milk production [37]. Development of the mammary epithelial cells during
pregnancy has been shown to influence transport pathways in the mammary gland responsible for
different protein profiles of milk [38]. Moreover, insulin has been shown to be actively transported into
milk and maternal diabetes affect milk insulin levels [39]. Maternal factors such as diet, lifestyle and
phenotype have been shown to influence the milk composition [26]. Moreover, secretor status is also
important for the biosynthesis of milk oligosaccharides [26]. The presence of α1,2 fucosyltransferase
gene (FUT2) is important for the milk oligosaccharides since non-secretors, which lack the FUT2 gene,
are unable to biosynthesize HMOs with a fucose bound to a N-acetylglucosamine via a glycosidic α1,2
linkage. Non-secretor status occurs in approximately 20% of most human populations [40,41]. In the
present study, non-secretor status, identified by increased level of 3-FL, was found in 28.9 % of milk
donors. Gestational age and the stage of lactation are also known to influence the milk proteins [14],
lipids [42], and lactose [43]. Preliminary HM metabolomic studies have shown a difference between
the metabolite profiles of pre-term and full-term HM [22,24]. Additionally, the metabolite extraction
procedure in sample preparation prior to NMR spectroscopy has shown to influence the milk metabolite
levels. In a recent paper, a sample preparation method using ultrafiltration as employed in the present
study, was found to be superior compared with methanol/chloroform extraction in terms of separating
small molecules from proteins and lipids [28]. Levels of HMO and its components are known to
decrease with time [44]. A specific HMO, lacto-N-tetraose, has also been shown to be elevated in
pre-term milk [45]. Interestingly, specific HMOs, LNDFH I, 3’-sialyllactose, and 6’-sialyllactose, and
common components of HMO, including fucose, N-acetylglucosamine, and N-acetylneuraminic acid
were identified to be present in higher concentrations in pre-term milk. HMOs have previously been
shown to prevent necrotizing enterocolitis in neonatal rats [6], which may be linked to alterations in
the microbiota of the infant’s gut [46]. Thus, the elevated amounts of HMOs in pre-term milk may be
a factor in the observed association of lower rates of necrotizing enterocolitis in premature infants fed
HM [5].
Most of the free amino acids in HM steadily decrease in level as the milk matures [42]. However,
the pre-term milk amino acid composition has not been well characterized throughout the course of
lactation [47–49]. Glutamate is known to increase with lactation time [47] and this was also found in
both pre-term and full-term milk in the present study. Valine and leucine, two essential amino acids,
were found at the highest concentration in full-term colostrum and decreased with time postpartum,
in agreement with other human milk metabolomics studies [27]. In contrast, increases in valine and
leucine levels were observed in pre-term milk with time post-partum, which is in contrast to the
pattern observed in full-term milk and that previously reported for pre-term milk [48,49].
Short- and medium-chain fatty acids (SMCFA; butyrate, caprylate, and caprate) were found in
higher concentrations in full-term milk compared with pre-term milk. Moreover, the levels of SMCFA
increased with time postpartum, as previously reported [50]. Choline is of high nutritional value, as it
is abundant in cell membranes and acts as a precursor for the important messenger acetylcholine, and
infants require high amounts of choline in order to sustain their rapid growth. Phosphocholine was
found in higher levels in pre-term milk than in full-term milk, which is in agreement with previous
reports on phosphocholine [51]. In contrast, pre-term milk has previously been shown to contain lesser
amounts of choline [51], which is contradictory to findings in the present study.
In this study, it was shown that, after 5–7 weeks the metabolite profiles of pre-term milk resembled
that of full-term milk, independently of gestational age. For extremely early pre-term infants born
at a gestational age of, e.g., 24 weeks, these findings suggest that mother’s milk becomes equivalent
to mature milk for term infants by the time the infant reaches ~29 weeks post-menstrual age. This is
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a significant finding concerning a period in which the infant still requires advanced nutritional support
to maintain its growth and long-term developmental requirements. Clinical metabolomics could
potentially be advantageous to determine when milk metabolites levels become inadequate due to
maturation of milk, if causal relationships between milk metabolites and infant growth parameters can
be established. Previous studies have shown that protein concentration remains at higher levels in
pre-term human milk even after 8 weeks of lactation [13]; however, we believe this to be the first study
to document the changes in the metabolomics profile of pre-term human milk as it evolves to resemble
that of full-term milk, and to show that this occurs independent of gestational age at delivery.
In conclusion, specific differences in milk metabolites exist between milk from mothers delivering
pre-maturely and at term. Moreover, milk metabolite composition is associated with gestational
age and the metabolome of pre-term milk changes within 5–7 weeks postpartum to resemble that
of full-term milk, independent of time of gestation at delivery. However, as this study did not
systematically collect samples from a cohort of mothers in a longitudinal design, further studies of this
kind are recommended to more fully understand the significance of the changes reported herein.
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